Why the study?
Remnant cholesterol promotes atherosclerotic cardiovascular disease, but little is known regarding remnant cholesterol-related residual risk in patients with myocardial infarction with nonobstructive coronary arteries.
Does elevated remnant cholesterol predict major adverse cardiovascular events in patients with myocardial infarction with nonobstructive coronary arteries?
Does elevated remnant cholesterol predict major adverse cardiovascular events in patients with myocardial infarction with nonobstructive coronary arteries?
Elevated remnant cholesterol is an independent predictor of major adverse cardiovascular events in patients with MINOCA, improving risk discrimination when added to the TIMI risk score.
No takes yet. Share an insight, caveat, or question.
Elevated remnant cholesterol may refine MINOCA risk stratification; leaves open whether targeting it improves outcomes.
Gao et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: